跳至主要内容
临床试验/CTRI/2026/01/102126
CTRI/2026/01/102126尚未招募不适用

A comparative study: effectiveness of homoeopathic decimal and centesimal scales in the management of telogen effluvium aged 20–50 years using the HSVS and hair pull test –a individualised approach

Parul Institute of Homoeopathy and Research1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2026年3月2日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
To evaluate the usefulness of decimal and centesimal scale in the management of telogen effluvium.

研究概览

简要总结

This study is a comparative clinical study design to evaluate the usefulness of Homoeopathic medicines prescribed in decimal and centesimal scale in the management of Telogen Effluvium in aged group 20-50 years. The study will be conducted at Parul Institute of Homoeopathy and Research Hospital, Vadodara, with a total sample size of 30 patients and a study duration of 3 months. Each patient will receive  individualised homoeopathic treatment based on detailed case taking and totality of symptoms. the outcome of the study will be the assessment of improvement in hair shedding by using hair shedding visual scale and hair pull test before and after treatment and also in every follow ups. Patients will be divided into two groups, each receiving homoeopathic treatment in either decimal or centesimal potency scales. The results will be statistically analyzed to compare the efficacy of both scales. The study aims to provide scientific evidence regarding the most effective potency scale in the management of telogen effluvium.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • •Patients diagnosed with telogen effluvium, confirmed through clinical history and positive hair pull test.
  • •Post-febrile illness (e.g., after dengue, typhoid, covid-19, influenza).
  • •postpartum state (within 12 months of delivery).
  • •Psychological stress, anemia, scalp infections or fungal diseases.

排除标准

  • •Patients with other forms of alopecia (e.g., alopecia areata, androgenetic alopecia, scarring alopecia).
  • •Pregnant or lactating women.
  • •Patients with underlying systemic disorders like: autoimmune diseases (e.g., lupus), diabetes mellitus, pcod, thyroid disorder and also patients on chemotherapy or radiotherapy.
  • •Patients currently using or having recently used topical steroids, minoxidil, or systemic treatments for hair loss.

结局指标

主要结局

To evaluate the usefulness of decimal and centesimal scale in the management of telogen effluvium.

时间窗: 3 months

次要结局

  • To assess improvement in hair fall using hair shedding visual scale.(3 months)

研究者

发起方
Parul Institute of Homoeopathy and Research
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Poojabahen Kanubhai Parmar

Parul institute of homoeopathy and research hospital

研究点 (1)

Loading locations...

相似试验